Carregant...
Does anti-reflux surgery disrupt the pathway of Barrett’s esophagus progression to cancer?
In patients with Barrett’s esophagus (BE), anti-reflux surgery aims to sustainable control reflux symptoms and heal reflux induced esophageal mucosal inflammation and prevent progression of BE to adenocarcinoma. There is growing evidence that beside gastric acid, bile salts in refluxed duodenal juic...
Guardat en:
| Publicat a: | Transl Gastroenterol Hepatol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327172/ https://ncbi.nlm.nih.gov/pubmed/30701208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tgh.2018.11.07 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|